Safety and quality of cystectomy and pelvic lymph node dissection after neoadjuvant durvalumab and cisplatin/gemcitabine.
Afferi L, Spahn M, Hayoz S, Strebel RT, Rothschild SI, Seifert H, Özdemir BC, Kiss B, Maletzki P, Engeler D, Wirth G, Hadaschik B, Lucca I, John H, Sauer A, Müntener M, Bubendorf L, Schneider M, Musilova J, Petrausch U, Cathomas R; Swiss Group for Clinical Cancer Research (SAKK).
Afferi L, et al. Among authors: maletzki p.
BJU Int. 2024 Sep;134(3):388-397. doi: 10.1111/bju.16318. Epub 2024 Mar 8.
BJU Int. 2024.
PMID: 38456541
Clinical Trial.